Expert Opinion on Biological Therapy, Volume 17, Issue 10 (2017)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Biological Therapy, Volume 17, Issue 10 (2017)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Volume 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Editorial

Editorial
Current views on Zika virus vaccine development
Luisa Barzon & Giorgio Palù
Pages: 1185-1192
Published online: 26 Jun 2017
First Page PreviewforCurrent views on Zika virus vaccine development | Full Text | References | PDF (733.4 KB)
  • 2803 Views
  • 18 CrossRef citations
  • 0Altmetric
Free Access

Review

Review
Working towards dengue as a vaccine-preventable disease: challenges and opportunities
Ambuj Shrivastava, Nagesh K Tripathi, Paban K. Dash & Manmohan Parida
Pages: 1193-1199
Published online: 24 Jul 2017
AbstractforWorking towards dengue as a vaccine-preventable disease: challenges and opportunities | Full Text | References | PDF (883.1 KB)
  • 334 Views
  • 12 CrossRef citations
  • 0Altmetric
Review
Allogeneic cell therapy manufacturing: process development technologies and facility design options
Saeed Abbasalizadeh, Mohammad Pakzad, Joaquim M.S. Cabral & Hossein Baharvand
Pages: 1201-1219
Published online: 20 Jul 2017
AbstractforAllogeneic cell therapy manufacturing: process development technologies and facility design options | Full Text | References | PDF (1.8 MB)
  • 1141 Views
  • 23 CrossRef citations
  • 0Altmetric
Review
Challenges and opportunities in the manufacture and expansion of cells for therapy
Joachim H. Maartens, Elena De-Juan-Pardo, Felix M. Wunner, Antonio Simula, Nicolas H. Voelcker, Simon C. Barry & Dietmar W. Hutmacher
Pages: 1221-1233
Published online: 18 Aug 2017
AbstractforChallenges and opportunities in the manufacture and expansion of cells for therapy | Full Text | References | PDF (2.1 MB)
  • 558 Views
  • 11 CrossRef citations
  • 0Altmetric
Review
Gene therapy for age-related macular degeneration
Nicholas A. Moore, Peter Bracha, Rehan M. Hussain, Nuria Morral & Thomas A. Ciulla
Pages: 1235-1244
Published online: 20 Jul 2017
AbstractforGene therapy for age-related macular degeneration | Full Text | References | PDF (945.7 KB)
  • 1705 Views
  • 45 CrossRef citations
  • 0Altmetric
Review
Genome editing: the breakthrough technology for inherited retinal disease?
Andrew J. Smith, Stephen P. Carter & Breandán N. Kennedy
Pages: 1245-1254
Published online: 11 Jul 2017
AbstractforGenome editing: the breakthrough technology for inherited retinal disease? | Full Text | References | PDF (1.2 MB)
  • 566 Views
  • 8 CrossRef citations
  • 0Altmetric
Review
Treating breast cancer with cell-based approaches: an overview
Susanna Gallo, Dario Sangiolo, Fabrizio Carnevale Schianca, Massimo Aglietta & Filippo Montemurro
Pages: 1255-1264
Published online: 20 Jul 2017
AbstractforTreating breast cancer with cell-based approaches: an overview | Full Text | References | PDF (775.4 KB)
  • 324 Views
  • 4 CrossRef citations
  • 0Altmetric
Review
Adeno-Associated Virus (AAV) gene therapy for cystic fibrosis: current barriers and recent developments
William B. Guggino & Liudmila Cebotaru
Pages: 1265-1273
Published online: 06 Jul 2017
AbstractforAdeno-Associated Virus (AAV) gene therapy for cystic fibrosis: current barriers and recent developments | Full Text | References | PDF (707.3 KB)
  • 1118 Views
  • 38 CrossRef citations
  • 0Altmetric

Drug Evaluation

Article
Idarucizumab for the treatment of hemorrhage and dabigatran reversal in patients requiring urgent surgery or procedures
Ovidiu Vornicu, Anne-Sophie Larock, Anne-Sophie Dincq, Jonathan Douxfils, Jean-Michel Dogné, François Mullier & Sarah Lessire
Pages: 1275-1296
Published online: 20 Jul 2017
AbstractforIdarucizumab for the treatment of hemorrhage and dabigatran reversal in patients requiring urgent surgery or procedures | Full Text | References | PDF (1.9 MB)
  • 234 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Anti-EGFR monoclonal antibody panitumumab for the treatment of patients with metastatic colorectal cancer: an overview of current practice and future perspectives
Francesca Battaglin, Vincenzo Dadduzio, Francesca Bergamo, Chiara Manai, Marta Schirripa, Sara Lonardi, Vittorina Zagonel & Fotios Loupakis
Pages: 1297-1308
Published online: 28 Jul 2017
AbstractforAnti-EGFR monoclonal antibody panitumumab for the treatment of patients with metastatic colorectal cancer: an overview of current practice and future perspectives | Full Text | References | PDF (1,014.6 KB)
  • 920 Views
  • 17 CrossRef citations
  • 0Altmetric
Article
Nivolumab for the treatment of bladder cancer
Oliver W. Hakenberg
Pages: 1309-1315
Published online: 24 Jul 2017
AbstractforNivolumab for the treatment of bladder cancer | Full Text | References | PDF (601.1 KB)
  • 465 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
MEDI 4736 (durvalumab) in non-small cell lung cancer
Arnaud Jeanson & Fabrice Barlesi
Pages: 1317-1323
Published online: 13 Jul 2017
AbstractforMEDI 4736 (durvalumab) in non-small cell lung cancer | Full Text | References | PDF (763.7 KB)
  • 1019 Views
  • 12 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

An evaluation of nadofaragene firadenovec-vncg for the treatment of high-risk BCG-unresponsive non-muscle-invasive bladder cancer
Zine-Eddine Khene et al.
Review Article | Published online: 11 Jun 2024
Progress in second-line antibody therapies for advanced esophageal squamous cell carcinoma
Nozomu Ogura et al.
Review Article | Published online: 11 Jun 2024
Overview of biosimilar medicines in Spain: market dynamics, policies, evidence-based insights and avenues for a sustainable market
Isabel Río-Álvarez et al.
Review Article | Published online: 6 Jun 2024
Non-TNF biologics and their biosimilars in rheumatoid arthritis
Tsz Ching Mok et al.
Review Article | Published online: 22 May 2024
View all latest articles